sequence Search Results


dna clean up  (Zymo Research)
97
Zymo Research dna clean up
Dna Clean Up, supplied by Zymo Research, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna clean up/product/Zymo Research
Average 97 stars, based on 1 article reviews
dna clean up - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier
single cell portal  (Broad Clinical Labs)
96
Broad Clinical Labs single cell portal
Single Cell Portal, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single cell portal/product/Broad Clinical Labs
Average 96 stars, based on 1 article reviews
single cell portal - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
sequence  (Teva)
86
Teva sequence
Sequence, supplied by Teva, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequence/product/Teva
Average 86 stars, based on 1 article reviews
sequence - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
primer sequences  (Eurofins)
86
Eurofins primer sequences
Primer Sequences, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primer sequences/product/Eurofins
Average 86 stars, based on 1 article reviews
primer sequences - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
sequence tci stateid tci stateid qcl type1 qcl info  (Tokyo Chemical Industry)
86
Tokyo Chemical Industry sequence tci stateid tci stateid qcl type1 qcl info
Sequence Tci Stateid Tci Stateid Qcl Type1 Qcl Info, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequence tci stateid tci stateid qcl type1 qcl info/product/Tokyo Chemical Industry
Average 86 stars, based on 1 article reviews
sequence tci stateid tci stateid qcl type1 qcl info - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
lv  (Shanghai Genechem Ltd)
86
Shanghai Genechem Ltd lv
Lv, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lv/product/Shanghai Genechem Ltd
Average 86 stars, based on 1 article reviews
lv - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
basespace sequence hub  (Illumina Inc)
95
Illumina Inc basespace sequence hub
Basespace Sequence Hub, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/basespace sequence hub/product/Illumina Inc
Average 95 stars, based on 1 article reviews
basespace sequence hub - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
illumina tso kit  (Illumina Inc)
96
Illumina Inc illumina tso kit
Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement <t>(NPA,</t> <t>PPA,</t> Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology <t>TSO</t> 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.
Illumina Tso Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illumina tso kit/product/Illumina Inc
Average 96 stars, based on 1 article reviews
illumina tso kit - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
nextseq 550dx platform  (Illumina Inc)
96
Illumina Inc nextseq 550dx platform
Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement <t>(NPA,</t> <t>PPA,</t> Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology <t>TSO</t> 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.
Nextseq 550dx Platform, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nextseq 550dx platform/product/Illumina Inc
Average 96 stars, based on 1 article reviews
nextseq 550dx platform - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
trusight one sequencing panel tso  (Illumina Inc)
96
Illumina Inc trusight one sequencing panel tso
Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement <t>(NPA,</t> <t>PPA,</t> Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology <t>TSO</t> 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.
Trusight One Sequencing Panel Tso, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trusight one sequencing panel tso/product/Illumina Inc
Average 96 stars, based on 1 article reviews
trusight one sequencing panel tso - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
illumina trusight myeloid panel  (Illumina Inc)
96
Illumina Inc illumina trusight myeloid panel
Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement <t>(NPA,</t> <t>PPA,</t> Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology <t>TSO</t> 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.
Illumina Trusight Myeloid Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illumina trusight myeloid panel/product/Illumina Inc
Average 96 stars, based on 1 article reviews
illumina trusight myeloid panel - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
trusight hereditary cancer panel  (Illumina Inc)
96
Illumina Inc trusight hereditary cancer panel
Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement <t>(NPA,</t> <t>PPA,</t> Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology <t>TSO</t> 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.
Trusight Hereditary Cancer Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trusight hereditary cancer panel/product/Illumina Inc
Average 96 stars, based on 1 article reviews
trusight hereditary cancer panel - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

Image Search Results


Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement (NPA, PPA, Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology TSO 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.

Journal: medRxiv

Article Title: Combination of BRCA deep targeted sequencing and shallow whole genome sequencing to detect homologous recombination deficiency in ovarian cancer

doi: 10.1101/2024.09.10.24313378

Figure Lengend Snippet: Sensitivity of the HRD INSIGHT assay to detect (A) germline and somatic SNV and small Indel mutations, (B) germline large genomic rearrangements (LGRs) of BRCA1/2 genes in reference standards. (C) Concordance of the HRD INSIGHT assay to determine the genomic instability score and status of the reference standards. (D) Positive-, negative- and overall-percent agreement (NPA, PPA, Overall) of the HRD INSIGHT assay with the HRD Focus Panel (AmoyDx), TruSight Oncology TSO 500 HRD (Illumina) and SOPHiA DDM HRD Solutions (Sophia Genetics) to determine HRD status of clinical FFPE ovarian samples. For 4 conflicting samples, the results of individual assays were shown.

Article Snippet: While the PPA and NPA among all assays were mostly above 90%, the HRD INSI assay shared the lowest PPA with the AmoyDx kit (94.7%) and the lowest NPA with the Illumina TSO kit (81.3%).

Techniques:

(A) The successful rate of each assay to determine HRD status of clinical samples. (B) Distribution of noise index and DNA integrity number among samples that failed AmoyDx test. (C) Noise reduction algorithm improved the correlation of wGI score with TSO genomic instability (GIS) score. (D) Tumor fraction (TF) was determined in-silico and compared with AmoyDx and TSO kits. (E) In-silico simulation of TF serial dilution at different levels showed stable wGI scores at a minimum TF of 30%. (F) wGI score measurement was robust and reproducible among different runs across different sequencing platforms.

Journal: medRxiv

Article Title: Combination of BRCA deep targeted sequencing and shallow whole genome sequencing to detect homologous recombination deficiency in ovarian cancer

doi: 10.1101/2024.09.10.24313378

Figure Lengend Snippet: (A) The successful rate of each assay to determine HRD status of clinical samples. (B) Distribution of noise index and DNA integrity number among samples that failed AmoyDx test. (C) Noise reduction algorithm improved the correlation of wGI score with TSO genomic instability (GIS) score. (D) Tumor fraction (TF) was determined in-silico and compared with AmoyDx and TSO kits. (E) In-silico simulation of TF serial dilution at different levels showed stable wGI scores at a minimum TF of 30%. (F) wGI score measurement was robust and reproducible among different runs across different sequencing platforms.

Article Snippet: While the PPA and NPA among all assays were mostly above 90%, the HRD INSI assay shared the lowest PPA with the AmoyDx kit (94.7%) and the lowest NPA with the Illumina TSO kit (81.3%).

Techniques: In Silico, Serial Dilution, Sequencing